In the all-randomised population, tests for difference of Xeloda vs 5-FU/ LV in disease-free and overall survival showed hazard ratios of 0.88 (95% CI 0.77 – 1.01; p = 0.068) and 0.86 (95% CI 0.74 – 1.01; p = 0.060), respectively.
Kogu randomiseeritud populatsioonis näitasid Xeloda vs 5- FU/ LV erinevuse testid haigusvaba ja üldise elulemuse riski suhet vastavalt 0, 88 (95% CI 0, 77 - 1, 01; p = 0, 068) ja 0, 86 (95% CI 0, 74 - 1, 01; p = 0, 060).